Serious Adverse Event Reconciliation

Slides:



Advertisements
Similar presentations
CROMS NIDCR Clinical Monitoring
Advertisements

Tips to a Successful Monitoring Visit
Susan Burner Bankowski, M.S., J.D. Chair, OHSU IRB
Adverse Events and Serious Adverse Events
Safety Reporting IN Clinical Trials
ADVERSE EVENT REPORTING
Focused on Pulmonology and Hepatology
Adverse Event Reporting. Reporting Adverse Events Adverse Events (AEs) are “... any untoward medical occurrence in a subject that was not previously identified.
Reporting Unanticipated Problems Involving Risk to Subjects or Others and Adverse Events WFUHS Policy/Procedure Effective Date 6/1/07 Wendy Murray Monitoring.
SAE Reconciliation How to handle ‘a waterfall’ of SAEs?
The Language of Clinical Trials. Objectives Objectives: At the conclusion of this discussion, participants will be able to: –Define clinical research.
Brookhaven Science Associates U.S. Department of Energy 1 Brookhaven National Laboratory Protocol Compliance Monitoring Darcy Mallon May 7, 2009.
Using EDC-Rave to Conduct Clinical Trials at Genentech
Basic Pharmacovigilance Training
Clinical Data Management is involved in all aspects of processing the clinical data, working with a range of computer applications, database systems.
SAE Report CTT21 V To:Quality Assurance Research & Development 34 Hyde Terrace LS2 9LN Date:…………………………….. Fax To:+44(0) From (name):………………………..
Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial Adverse Event Reporting Catherine Dillon.
ACRIN 6698 Diffusion-weighted MRI Biomarkers for Assessment of Breast Cancer Response to Neoadjuvant Treatment: An I-SPY 2 Trial Substudy Presented by:
Adverse Events, Unanticipated Problems, Protocol Deviations & other Safety Information Which Form 4 to Use?
SERIOUS ADVERSE EVENTS REPORTING Elizabeth Dayag IRB Administrator Naval Medical Center Portsmouth.
Adverse Events and Unanticipated Problems Presented by: Karen Jeans, PhD, CCRN, CIP COACH Program Analyst.
Paula Peyrani, MD Division of Infectious Diseases University of Louisville Performing the Study.
Adverse Event Reporting.
Office of Research Oversight ORO Reporting Adverse Events in Research to ORO Paula Squire Waterman, MS, CIP Department of Veterans Affairs Office of Research.
H. Lundbeck A/S21-Sep-151 Pharmacovigilance during clinical development SAE reporting, ASUR and PSUR IFF Seminar, 21. February 2007.
SAE Reporting Judy Breed, BA, RN June, 2011 CONFIDENTIAL.
Adverse Event/Unanticipated Problems Policy and Procedures November 2007.
Andrace DeYampert Bethany Lane Samkeliso Mawocha ProTECT III Investigator Meeting November 12-14, 2012.
AE/SAE/EAE Identification and Reporting AE/SAE/EAE Identification and Reporting.
SAE data entry: Clinical versus Pharmacovigilance standards Daniel Becker Solvay Pharmaceuticals Hannover, Germany T:
EAE Training EAE Reporting and Assessment Overview DAIDS Regional Training Event, Regulatory Compliance Center Kampala, Uganda, September 2009 DAIDS Regional.
Investigator’s Meeting
Agenda Introduction Study Objectives Study Design Delegation
Serious Adverse Event Reporting Start-up Meeting March 25, 2010 Kingston, ON.
European Patients’ Academy on Therapeutic Innovation Introduction to pharmacovigilance Monitoring the safety of medicines.
Stress Ulcer Prophylaxis in the Intensive Care Unit (SUP-ICU) SAR/SUSAR Mette Krag Dept. of Intensive Care 4131 Copenhagen University Hospital Rigshospitalet,
Role of Site Investigator Ensure subject safety is protected & well-managed Full compliance with requirements of Good Clinical Practice (GCP) Conduct the.
D3 ) Not Recovered d5) Fatal Was a post-mortem undertaken?YesNo Was the SAE ongoing at time of death from other cause? Yes No d d m m y y y y d1) Recovered.
Responsibilities of Sponsor, Investigator and Monitor
1 SAE Centralized Report and Review Process April 2012.
Sponsor Visits and Monitoring Barbara Gallagher, RN Clinical Research Nurse Jefferson Clinical Research Institute.
REPORTING ADVERSE EVENTS AND COMPLETING THE REPORT FORM
Safety of the Subject Cena Jones-Bitterman, MPP, CIP, CCRP
The Role and Responsibilities of the Clinical Research Coordinator
Responsibilities of Sponsor, Investigator and Monitor
Reportable Events Emory IRB 9/11/2014.
FHIR Adverse Event Resource
Safety Reporting V6.0 17/01/17.
MAINTAINING THE INVESTIGATOR’S SITE FILE
HOW TO ENTER BASELINE DATA
Safety Reporting Nichol McBee, MPH, CCRP.
Expedited Adverse Event Reporting Requirements
Remote Monitoring of Adverse Events
Copenhagen University Hospital Rigshospitalet, Denmark
3. Key definitions Multi-partner training package on active TB drug safety monitoring and management (aDSM) July 2016.
Pharmacovigilance in clinical trials
Safety of the Subject Cena Jones-Bitterman, MPP, CIP, CCRP
Expedited Adverse Event Reporting Requirements
*Continue on SAE supplemental page CTT21 A if more space is required
CLINICAL DATA MANAGEMENT
Remote Monitoring of Adverse Events
SERIOUS ADVERSE EVENTS REPORTING
MAINTAINING THE INVESTIGATOR’S STUDY FILE
WHAT TO DO IF A PATIENT DEVELOPS AN UNEXPECTED PROBLEM?
Data Management in Support of A Clinical Event Committee (CEC)
E-CRF Overview Oracle® Clinical Remote Data Capture Training (Version 4.6 HTML) e-CRF Completion John McDonach Manager CDM, PPD.
Model Enhanced Classification of Serious Adverse Events
Adverse Event Reporting _____________________________
Discrepancy Management
Dr Tim England TICH-2 SAE adjudicator
Presentation transcript:

Serious Adverse Event Reconciliation - Aditi Bhat

Agenda Adverse Event Serious Adverse Event (SAE) Collection of SAE’s SAE Reconciliation and Reasons for performing reconciliation Different databases Paper studies and Electronic studies Points/Fields to be reconciled Points to remember before performing SAE reconciliation Reconciliation Process Discrepancy with solutions Query process Roles and Responsibility Data base lock activity Documents

Adverse Event An adverse event is any unfavourable and unintended sign (including abnormal laboratory findings), symptoms or disease temporarily associated with the use of a medical (investigational) product, whether or not related to the medical (investigational) product.

Serious Adverse Event SAE (Serious Adverse Event) : Any untoward medical occurrence that at any dose results in:- Death Is life threatening Requires inpatient hospitalization or prolongation of existing hospitalization Persistent or significant disability/incapacity Congenital anomaly or birth defect Requires intervention to prevent impairment or damage

Collection of SAE’s When SAE is reported on the site, it has to be reported to the Sponsor within 24 hours and to regulatory authorities within 7 days. If the Site does not adhere to the mentioned timelines, it will be considered as protocol deviation.

SAE Reconciliation and reasons for performing reconciliation It is necessary because SAE data is considered as CRITICAL DATA in both the safety and the project database. Clinical database is made up of dosing, demography, adverse event and final subject summary pages; all of which are data points that make up the case that are reported to the safety database. It is essential to understand that these data is submitted to Regulatory Agencies at the end of the study and for subsequent aggregate reporting which occurs well after database lock.

Different databases used to perform reconciliation Safety database: Sapphire BOR, Argus, etc. (Mainly built for Pharmacovigilance purpose) Clinical database: AMOS, RAVE, COOL, INFORM, ORACLE

Paper studies Electronic studies Data is entered on Paper case Report Form Data entry associates will enter the data manually in Clinical database Example: AMOS Data is captured in electronic case report Form Investigator enters data in to database Examples: RAVE, INFORM

Fields to be reconciled Site Number Subject Number Randomization Number AE Term reported (verbatim Term) Preferred term (Coded Term) Start date of the event Stop date of the event Investigational drug Causality Outcome Seriousness criteria AE became SAE date

Points to remember before performing reconciliation Reading of Data Handling Plan and Protocol are MUST before starting the reconciliation of the study which will give the below details, When to start SAE reconciliation considering First Patient First Visit Which fields to be reconciled What would be the cutoff date for SAE Which SAEs to be considered as expected SAEs, Unexpected SAEs, Which SAEs to be considered as End points. End points are to be captured or not Details of CRA, Investigator, CTH Frequency of reconciliation to be performed

Process of reconciliation Team Lead will assign the study Apply for the required access Read Protocol and DHP Post getting the access send mail to study team to discuss the reconciliation date for the particular study Pull the safety listings from Safety database / request for the Safety listings And pull the Clinical listings by SAS or the available tool Perform the reconciliation Record the discrepancies and action to be taken in one sheet [generally called as SAE reconciliation Spread Sheet (SRS)] Raising queries - For missing SAEs query should be raised within 24 hours of the reconciliation Before raising a query, kindly check if the query has been raised by TDM/DM for the particular SAE

Discrepancies with resolutions

Query Process For missing SAEs from either of the database, query to be raised within 24 hours of the reconciliation process If Query is not getting answered in 48 hours for missing SAE, send mail to CRA keeping CTH and study team in loop For other discrepancies turn over time is 7 working days Before raising any query, please check if the query has been raised Every week Open query report to be run and if answers of raised queries are satisfactory in nature, query can be closed. If not a re-query can be raised After raising 3 re-queries, answer is not satisfactory; send mail to CRA keeping study team in a loop

Roles and Responsibility SAE Reconciler: Extracting the data from Clinical database and Safety database Reconciliation mandatory/agreed upon SAE data points Communicating with coders to resolve the coding issue Checking internally with data entry to resolve data entry issues if the study is paper based Raising queries in the database Preparing SRS log for discrepancies observed and action taken Filling the monthly ongoing reconciliation form Filling the Final SAE Reconciliation form.

Database lock activity SAE Reconciler will receive a mail regarding database lock from study team. He/she needs to confirm about cutoff date regarding SAE Frequency of reconciliation will be discussed with the study team. Query report to be pulled on a regular basis If queries are not getting resolved, mail can be sent to CRA keeping study team in a loop Discrepancy report can be sent to the study team Patient safety to be reported for the database lock.

Documents SAE Reconciliation Spreadsheet Monthly Ongoing SAE Reconciliation Form Safety Database update Request Form Coding Mismatch Tracker Final SAE Reconciliation Form

Questions

Thanks